Scale Biosciences

Scale Biosciences is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in single-cell analysis technologies, aiming to make complex biology research more scalable, accessible, and cost-effective. Their core innovation includes patented combinatorial indexing and quantum barcoding, which allows researchers to analyze hundreds to millions of cells across various samples and conditions. The company offers a range of single-cell library preparation kits, including their flagship QuantumScale Single Cell RNA kits. These products support diverse applications such as RNA sequencing, methylation profiling, and CRISPR screening. Scale Biosciences serves academic researchers, biotechnology firms, and pharmaceutical organizations, focusing on making single-cell analysis routine and widely accessible. In 2025, Scale Biosciences was acquired by 10x Genomics, integrating their technologies into the 10x platform to further enhance single-cell analysis capabilities.